The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study): A randomized controlled trial

JAMA

Volumn 276, Issue 17, 1996, Pages 1397-1403

  Speroff, Leon ^a   Rowan, Jean ^b,e   Symons, James ^b,e   Genant, Harry ^c   Wilborn, Walter ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Structural Research Center   (United States)

^e Parke Davis Pharmaceutical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORETHISTERONE ACETATE; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EDEMA; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; LIPID METABOLISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MASTALGIA; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET; WEIGHT GAIN;

EID: 0029992572     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.17.1397     Document Type: Article

References (30)

1. Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804-1809.
2. Hui SL, Slemenda CW, Johnston CC Jr. Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 1989;111:356-361.
3. Kroger H, Huopio J, Honkanen R, et al. Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. J Bone Miner Res. 1995;10:302-306.
4. Jensen GF, Christiansen C, Boesen J, Hegedus V, Transbøl I. Epidemiology of postmenopausal spinal and long bone fractures: a unifying approach to postmenopausal osteoporosis. Clin Orthop. 1982;166:75-81.
5. Delva MD. Hormone replacement therapy: risks, benefits, and costs. Can Fam Physician. 1993;39: 2149-2154.
6. Lindsay R. The growing problem of osteoporosis. Osteoparos Int. 1992;2:267-268.
7. Christiansen C, Christensen MS, Transbøl I. Bone mass in postemenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet. 1981;1:459-461.
8. Barrett-Connor E. Risks and benefits of replacement estrogen. Annu Rev Med. 1992;43:239-251.
9. Genant HK, Baylink DJ, Gallagher JC. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol. 1989;161:1842-1846.
10. Lafferty FW, Fiske ME. Postmenopausal estrogen replacement: a long-term cohort study. Am J Med. 1994;97:66-77.
11. Whitehead MI, Townsend PT, Pryse-Davies J, Ryder TA, King RJB. Effects of estrogen and progestin on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med. 1981; 305:1599-1605.
12. Deligdisch L. Effects of hormone therapy on the endometrium. Mod Pathal. 1993;6:94-106.
13. Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for post-menopausal osteoporosia. Br J Obstet Gynaecol. 1992;99:325-328.
14. Williams SR, Frenchek B, Speroff T, Speroff L. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. Am J Obstet Gynecol. 1990;162:438-446.
15. Fleiss JL. The Design and Analysis of Clinical Experiments. New York, NY: John Wiley & Sons Inc; 1986.
16. Genant HK, Cann CE, Ettinger B, Gordan GS. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982;97:699-705.
17. Glüer CC, Faulkner KG, Estilo MJ, Engelke K, Rosin J, Genant HK. Quality assurance for bone densitometry research studies: concept and impact. Osteoporos Int. 1993;3:227-235.
18. Laval Jeantet AM, Genant HK, Wu CY, Glüer CC, Faulkner KG, Steiger P. Factors influencing long-term in vivo reproducibility of QCT vertebral densitometry. J Camput Assist Tamogr. 1993;17:915-921.
19. Estilo MJ, Glüer CC, Faulkner KG, Laval-Jeantet AM, Engelke K, Genant HK. Long-term precision and longitudinal sensitivity in vivo of quantitative computed tomography and dual x-ray absorptiometry. J Bone Miner Res. 1991;6(suppl 1):S335.
20. Blunt BA, Glüer CC, Brastow PC, Rosin JD, Jergas M, Genant HK. Patient data correction factor for multi-center trials using quantitative computed tomography. J Bone Miner Res. 1993;8(suppl 1):S356.
21. Eiken P, Kolthoff N. Compliance with long-term oral hormonal replacement therapy. Maturitas. 1995;22:97-103.
22. Hahn RG, Nachtigall RD, Davies TC. Compliance difficulties with progestin-supplemented therapy. J Fam Pract. 1984;18:411-414.
23. Hemminiki E, Brambilla DJ, McKinlay SM, Posner JG. Use of estrogen among middle-aged Massachusetts women. DICP. 1991;25:418-423.
24. Wren BG, Brown L. Compliance with hormonal replacement therapy. Maturitas. 1991;13:17-21.
25. Barentsen R, Groeneveld F, Bareman FP, Hoes AW, Dokler HJ, Drogendijk AC. Women's opinion on withdrawal bleeding with hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol. 1993; 51:203-207.
26. Archer DF, Pickar MD, Bottiglioni F, for the Menopause Study Group. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol. 1994; 83:686-692.
27. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA. 1995;273:199-208. Correction: JAMA. 1995;274:1676.
28. Melton LJ III, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol. 1989; 129:1000-1011.
29. Ettinger B, Grady D. Maximizing the benefit of estrogen therapy for prevention of osteoporosis. Menopause. 1994;1:19-24.
30. Hankey BF, Brinton LA, Kessler LG, Abrams J. Breast. In: Miller BA, Reis LAG, Hankey, BF, et al, eds. SEER Cancer Statistic Review, 1973-1990. Bethesda, Md: US Dept of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute; 1991. US Dept of Health and Human Services publication NIH93-2789.